1. Introduction
===============

All cell types in the bodies of higher multicellular animals have extremely diverse phenotypes despite their genetic identity. A single zygote can divide and differentiate into a considerable number and wide variety of cells with unique genome sequences during development. The differences in the phenotypic characteristics among cell types result in different transcriptome and epigenome variations. As Waddington predicted in the 1950s,^[@r01])^ the differentiation and identity of the cells are governed by a non-genetic system for the regulation of gene expression termed "epigenetics". Although it has long been thought that terminally differentiated somatic cells cannot cross over the "epigenetic barrier" and trans-differentiate into other cell types, some somatic cells have plasticity for de- or re-differentiation, *e.g.*, cardiomyocytes in zebrafish hearts^[@r02],[@r03])^ and pigmented epithelial cells in newt eyes.^[@r04])^ These examples suggest that terminally differentiated animal cells can convert into other cell types.

In 2006, Takahashi and Yamanaka initialized the cell fate of fibroblasts from adult mammals and re-differentiated them into various cell lineages through the forced transduction of a defined set of transcription factors.^[@r05])^ Their study provided information regarding the nature of cell differentiation as well as the possibility of induced pluripotent stem cell (iPSC)-based regenerative therapies. Indeed, many basic and applied studies have been performed for the realization of iPSC-based regenerative medicine. The successful application of this type of medicine has been reported, including for clinical trials of cell transplantation therapy for age-related macular degradation,^[@r06])^ Parkinson's disease,^[@r07])^ and corneal epithelial stem cell deficiency.^[@r08])^ At present, clinical studies of other diseases, such as spinal cord injury, severe heart failure, and stroke, are being undertaken with regards to iPSC-based regenerative medicine. Furthermore, several drug discovery studies employing patient-derived iPSCs have identified a number of hopeful pharmaceutical candidates for treating fibrodysplasia ossificans progressiva,^[@r09])^ Pendred syndrome,^[@r10])^ Parkinson's disease,^[@r11])^ Alzheimer's disease,^[@r12])^ amyotrophic lateral sclerosis,^[@r13])^ and muscular dystrophy.^[@r14])^ In addition, the *in vitro* reconstruction of complicated and functional tissues and organs using iPSCs has also been reported, including in the brain,^[@r15])^ intestines,^[@r16])^ liver,^[@r17])^ and kidneys.^[@r18])^

Although iPSCs are a promising technology for future medicine, alternative methods for cell fate conversion, termed "direct reprogramming", have also been developed in the last decade. Direct reprogramming involves the trans-differentiation of somatic cells directly into other cell types without complete initialization. Before the first study regarding iPSCs, only a few types of direct reprogramming had been reported, including the reprogramming of fibroblasts into myoblast and pancreatic β cells. In recent studies, various cell types have been directly converted from other somatic cell types. Most of the direct reprogramming methods applied the forced transduction of defined sets of transcription factors to convert terminally differentiated cells into specific target cells artificially. Initially, only single-transcription factor-based direct reprogramming methods were reported.^[@r19]--[@r24])^ However, most recent studies for direct reprogramming employ a combinatorial transduction strategy similar to that of the iPSC, especially in the conversion between embryologically divided cell types. Although the combinatorial expression strategy of transcription factors with viral vectors is a powerful and stable technique for direct reprogramming, alternative methods are increasing because genomic integration of the transgenes causes genomic damage, and might induce unexpected functional attenuation, abnormal proliferation, and transformation. As explained above, the major applications of the direct reprogramming technologies are bedside clinical uses, such as cell transplantation and regenerative medicine. Meanwhile, other medical, *e.g.*, drug discovery and disease study, and non-medical, *e.g.*, livestock and pet industry, applications of the direct reprogramming technology have been used increasingly in recent years. Therefore, direct reprogramming technology will play a crucial role in both medical and non-medical industry.

2. Transcription factor-based direct reprogramming technologies
===============================================================

Similar to iPSC technology, most direct reprogramming methods employ forced expression of the defined set of transcription factors for cell-fate conversion (Table [1](#tbl01){ref-type="table"}). Many are tissue-specific or developmental process-related genes; thus, it is considered that these transcription factors act as a "kickstarter" to drive the cell type-specific transcription networks. Furthermore, almost all of the reprogramming factor gene sets contain at least one pioneer factor, which is a transcription factor capable of opening closed chromatin sections. These factors may play a pivotal role in the machinery of direct reprogramming. In this section, examples and applications for various types of transcription factor-based direct reprogramming are introduced.

2.1. Neuronal cells.
--------------------

By the end of 2018, the most reported target cells for direct reprogramming were neuronal lineage cells, including neural stem/progenitor cells (Fig. [1](#fig01){ref-type="fig"}). The first example of the direct lineage conversion to neuronal cells was the reprogramming of astrocytes toward glutamatergic neurons with the transduction of single transcription factors *in vitro*: Pax6, Mash1, or Ngn2.^[@r25])^ However, the presynaptic output function of the astrocyte-derived neurons was insufficient, and the conversion was only achieved between closely related cells. In 2010, more successfully reprogrammed neuronal cells, termed induced neuronal (iN) cells, were reported. Combinatorial transduction of a set of transcription factors, Brn2, Ascl1, and Myt1l, induced functional neuron-like cells from mouse embryonic fibroblasts (MEFs) and hepatocytes *in vitro*.^[@r26])^ One year later, some studies generated iN cells from human fibroblasts.^[@r27]--[@r29])^ Although the combination and member of the transcription factors in each study were different, only one transcription factor, Ascl1, was employed in almost every iN cell conversion method. This indicated that Ascl1 may be a vital regulator of neuronal reprogramming but can also be compensated for by other related factors. In addition to terminally differentiated neuronal cells, the direct induction of neural stem/progenitor cells, which are expandable and differentiate to a wide variety of neuronal lineage cells, was also reported.^[@r30]--[@r37])^ The combinations of transcription factors for the induction of neural stem/progenitor cells were significantly different from those of the differentiated iN cells; thus, this might indicate that the transcription networks in the differentiated neuronal cells and the neural stem/progenitor cells are significantly different. In recent years, studies on the generation of multipotent neural stem/progenitor cells have increased because these cells can proliferate *in vitro* for use in cell transplantation therapies.^[@r30]--[@r38])^ On the other hand, *in vivo* direct reprogramming studies for terminally differentiated iN cells are also increasing. In these studies, endogenous cells in the brain, such as glial cells, are converted into functional neuron-like cells *in situ* with plasmid transfection or viral vector infection.^[@r39]--[@r44])^ Furthermore, iN cells have been applied for non-therapeutic applications; for example, direct neuronal reprogramming of cells from patients with severe nerve diseases, such as Huntington's disease, amyotrophic lateral sclerosis, and myoclonus epilepsy associated with ragged red fibers, have been developed for pathological analysis and drug discovery studies.^[@r45]--[@r48])^

2.2. Cardiomyocytes.
--------------------

Cardiomyocytes, striated muscle cells in the heart, are the second most frequently reported target cells in the field of direct reprogramming (Fig. [1](#fig01){ref-type="fig"}). Cardiomyocytes are one of the most desirable cells for establishment in regenerative medicine because they are not expandable *in vivo* or *in vitro*. The first study of mouse-induced cardiomyocyte-like (iCM) cells was published in 2010,^[@r49])^ which was followed by other studies using different combinations of transcription factors.^[@r50],[@r51])^ Human fibroblast-derived iCM cells were established in 2013.^[@r52],[@r53])^ As well as iN cells, the combination of transcription factors for iCM cells shows wide variation, which might indicate redundancy of the transcription network of cardiomyocytes. However, only Tbx5 was included in all of the combinations of transcription factors for iCM cells. Therefore, it is considered that Tbx5 plays a central role in the transcription network of cardiomyocytes, similar to Ascl1 in neuronal cells. In previous studies, fibroblasts have frequently been employed as source cells for iCM cells because cardiac fibroblasts, which exist abundantly in the heart, are considered a potential candidate for source cells of *in situ* direct reprogramming. Some studies have achieved successful *in vivo* direct reprogramming of iCM cells in mouse hearts by using lentivirus vectors.^[@r50],[@r54])^ This technology may benefit patients with heart injury, such as myocardial infarction.

2.3. Hepatocytes.
-----------------

Hepatocytes are parenchymal cells of the liver and have vital roles in this organ, *i.e.*, lipid metabolism, glycogen accumulation, detoxification, and endocrine activities. As well as neuronal cells and cardiomyocytes, hepatocytes are also expected to be induced artificially for therapeutic uses because the specific functions of liver-derived hepatocytes cannot be maintained in canonical *in vitro* culture conditions and are unsuitable for cell transplantation therapy. Although iPSC-derived hepatocytes have been actively studied, the direct reprogramming of hepatocytes is also considered a promising alternative for regenerative treatments of the liver. The first studies of mouse-induced hepatocyte-like (iHep) cells were published by two independent groups simultaneously.^[@r55],[@r56])^ Although these studies used different protocols to induce iHep cells from fibroblasts, the resulting iHep cells showed similar phenotypes to those of endogenous hepatocytes, *i.e.*, secretion of albumin, uptake of low-density lipoprotein, and xenobiotic metabolism. Furthermore, studies were also conducted using human and mouse iHep cells in a wide variety of reprogramming factor combinations.^[@r55]--[@r64])^ The transcription network defining the cell fate of hepatocytes appears complex and may have redundancy. Among the transcription factors for iHep cell conversion, the Foxa family of transcription factors, *i.e.*, Foxa1, Foxa2, and Foxa3, are considered primary factors for hepatic reprogramming because almost all iHep cell induction methods employ this family proteins as well as Ascl1 and Tbx5 in other direct reprogramming methods. iHep cells are expected to have potential in cell transplantation therapies because the induced cells are expandable and maintain their hepatic functions, unlike the liver-derived hepatocytes. Nevertheless, the human iHep cells required unfavorable factors, such as a virus-derived gene, to be expandable cells; therefore, further improvements are necessary for the medical use of iHep cells. *In vivo* reprogramming of the iHep cells with an adeno-associated virus (AAV) vector is also studied to treat liver disorders, such as cirrhosis,^[@r60])^ because the fibrous liver contains a massive number of fibroblasts as source cells for the direct reprogramming and exclusion target cells.

2.4. Islet-related cells.
-------------------------

Among the five types of endocrine cells in pancreatic islets, β cells are the most critical targets for regenerative medicine because they are the unique source of insulin and are destroyed in type 1 diabetes. Of note, all of the cells reported to be reprogrammed into β cells were endoderm-derived cells, *e.g.*, hepatocytes, bile duct cells, pancreatic exocrine cells, and gallbladder cells, without exception.^[@r20],[@r21],[@r24],[@r65]--[@r71])^ The fact that only cells of closely related lineages have been converted into β cells might indicate the peculiarity of β cells from other lineages and plasticity among endoderm-derived cells. Relatively large numbers of studies of the *in vivo* direct reprogramming of these cells have been reported, because the generation of insulin-secreting cells in digestive organs is an easy and effective solution for type 1 diabetes.

2.5. Hematopoietic system-related cells.
----------------------------------------

Several terminally differentiated blood cells, *e.g.*, dendritic cells, macrophages, and T cells, were easily converted from other blood cells by transducing with single transcription factors.^[@r72],[@r73])^ Therefore, these studies were reported earlier the other direct reprogramming studies. On the other hand, the direct reprogramming of blood cells from fibroblasts requires much more complex sets of transcription factors.^[@r74]--[@r78])^ The long-distance lineage conversion appears to require a larger number of transcription factors than the short-distance lineage conversion to drastically change their transcription network. Toward practical use, the *in vitro* conversion of various types of blood cells has been studied vigorously to prepare cells for blood component transfusion.

2.6. Other types of cells.
--------------------------

Since the first report of the direct reprogramming of somatic cells into myoblasts in 1987,^[@r19])^ a vast number of different direct reprogramming techniques have been reported; for example, osteoblasts,^[@r79]--[@r82])^ myoblasts,^[@r19],[@r83])^ skeletal muscle progenitor cells,^[@r84])^ photoreceptor cells,^[@r85],[@r86])^ adipocytes,^[@r87],[@r88])^ smooth muscle cells,^[@r89],[@r90])^ sweat gland cells,^[@r91],[@r92])^ and endothelial cells^[@r93],[@r94])^ have been induced with several combinations of transcription factors. In addition, the direct conversion of various types of cells, such as brown fat cells,^[@r95])^ Sertoli cells,^[@r96])^ melanocytes,^[@r97])^ thymic epithelial cells,^[@r98])^ renal tubular epithelial cells,^[@r99])^ intestine progenitor cells,^[@r100])^ Leydig cells,^[@r101])^ trophoblast stem cells,^[@r102])^ and nephron progenitor cells,^[@r103])^ has been achieved successfully, and this method is expected to be applied in medical treatment, drug discovery, and pathological studies. Indeed, the researchers of some studies employed the directly reprogrammed cells from patient-derived somatic cells for their disease research.^[@r88],[@r104],[@r105])^

2.7. Prediction of the combinations of transcription factors.
-------------------------------------------------------------

Although most direct reprogramming studies select transcription factor combinations from factor lists developed in previous studies in genetics, genomics, and developmental biology, this type of screening is unreliable and inefficient. Therefore, several tools for the prediction of reprogramming factors have been developed. For these studies, a large amount of comprehensive biological data, *e.g.*, transcriptome and topologically associating domains, with computer algorithms, *e.g.*, machine learning and network analysis, were employed to develop the prediction model.^[@r106]--[@r110])^ These tools made the selection of transcription factor candidates and combinations easier. Therefore, the number and variation of direct reprogramming techniques using transcription factors will continue to increase.

3. Methods for direct cell fate conversion
==========================================

Although the majority of direct reprogramming has been achieved through the forced transduction of transcription factors with viral vectors, these methods are expected to be replaced with alternative methods (Table [2](#tbl02){ref-type="table"}). This is because frequently used viral vectors, retroviruses, and lentivirus vectors integrate the transgenes into the host genome and increase the risk of unexpected cell proliferation, transformation, and oncogenesis. Furthermore, although integration-free transduction methods, *e.g.*, adenovirus vectors, AAV vectors, and plasmid vectors, are employed, the possibility of accidental genome integration of foreign DNA remains. Therefore, integration-free, DNA-free, and transgene-free methods are desired for medical applications. In this section, a wide variety of technologies used in direct reprogramming studies are introduced.

3.1. Genome integration-free gene transduction.
-----------------------------------------------

Even now, transcription factors are one of the most powerful and useful tools for direct reprogramming. Therefore, several genome integration-free transduction methods have been applied for direct reprogramming instead of conventional viral vectors, such as retrovirus and lentivirus vectors. Sendai virus (SeV; hemagglutinating virus of Japan, HVJ) is an RNA virus that does not enter the nucleus and replicates in the cytoplasm. Therefore, vector systems using this virus are not at risk of genome integration of the transgenes. In addition to the induction of iPSCs,^[@r111])^ SeV vectors have been used for direct induction of photoreceptor cells from peripheral blood cells.^[@r112])^ Additionally, a method for *in vivo* cardiac reprogramming using SeV vectors achieved high reprogramming efficiency.^[@r113])^ These results suggested that the SeV vector system can be an alternative tool to induce cellular reprogramming based on the gene transduction method. Moreover, the envelope particle of the virus (HVJ-E) is a useful carrier of genes, siRNAs, proteins, and drugs. Human hepatocytes and neurocytes were induced from fibroblasts through the protein transduction technique with the HVJ-E carrier.^[@r62])^ The PiggyBac system is a transposon-based gene transduction technique. Although transgenes are integrated into the host genome, these sequences can be removed without any footprints with transposase. Some studies have employed this system and induced mouse hepatocytes^[@r114])^ and human nephron progenitor cells from somatic cells.^[@r103])^ mRNA transfection is an alternative gene transduction technique that is safer than previous methods. Since higher animals, including humans, do not have reverse transcriptase, there are no risks of integration of the transduced mRNAs into their genome. Many studies using mRNA transduction have been reported, *e.g.*, hepatocytes,^[@r59],[@r115])^ cardiomyocytes,^[@r116])^ neuronal cells,^[@r40])^ endothelial progenitor cells,^[@r117])^ and neural stem/precursor cells.^[@r34],[@r118])^ Nevertheless, several difficulties of this method, such as stability and transfection efficiency, remain. Solutions to these difficulties, such as the chemical modification of the mRNA^[@r34],[@r115])^ and specific transfection reagents,^[@r40],[@r116])^ have already been adopted in mRNA transfection studies. In addition to these methods, plasmid transfection has also been widely tested.^[@r27],[@r29],[@r32],[@r78],[@r116],[@r117])^ Although there is a risk of genome integration and a problem of low transduction efficiency, novel tools, such as a polysaccharide-based gene co-delivery system,^[@r119],[@r120])^ a Leu3p-αIPM system,^[@r121])^ or episomal vectors,^[@r122])^ might improve the plasmid-based transduction technologies.

3.2. Chemical compounds.
------------------------

Small chemical compounds that work as agonists or antagonists for various cellular reactions, such as signal transduction, the cell cycle, post-translational modification, apoptosis, epigenetics, and metabolism, have many advantages compared with gene transduction methods: 1) They are relatively more stable than biomolecules *in vitro* and *in vivo*. If they are not stable, chemical modifications can improve their stability. 2) Most can penetrate cells or organelles, unlike biopolymers. 3) There is no risk of genome integration of foreign sequences. 4) Suitable conditions for the chemicals are flexible and controllable.

Most chemicals used in the direct reprogramming studies have positive or negative effects for various signal transduction pathways, *e.g.*, Wnt (CHIR99021),^[@r123]--[@r129])^ cAMP (Forskolin),^[@r123],[@r125],[@r126],[@r128]--[@r130])^ TGFβ (RepSox, A83-01, SB431542),^[@r123]--[@r128],[@r131])^ Ca^2+^ (ISX9),^[@r126],[@r129])^ Shh (Purmorphamine),^[@r131],[@r132])^ Retinoic acid (TTNPB),^[@r123],[@r127])^ JAK/STAT (AZ960, SP600125),^[@r125],[@r133])^ Notch (DAPT),^[@r129])^ AMPK (dorsomorphin),^[@r130])^ PCK (GO6983),^[@r125])^ HIF (KC7F2),^[@r133])^ MAPK (PD0325901, ZM336372),^[@r124],[@r133])^ β1-integrin (Pyrintegrin),^[@r133])^ and Rho/ROCK (Thiazovivin, Y-27632)^[@r125],[@r131])^ signaling pathways, and epigenetic modifications, *e.g.*, histone lysine deacetylation (Valproic acid),^[@r42],[@r123]--[@r125],[@r127],[@r131])^ histone lysine acetylation recognition (I-BET151),^[@r126],[@r129])^ histone lysine methylation (Bix01294, Dznep),^[@r124],[@r127])^ DNA methylation (RG108),^[@r124])^ and DNA demethylation (Vitamin C).^[@r124])^ Although several types of cells, such as neuronal cells, hepatocytes, cardiomyocytes, and skeletal muscle progenitor cells, have been induced with chemicals, half of the reported studies used gene transduction in conjunction with the chemical treatments.^[@r42],[@r127],[@r128],[@r130],[@r132],[@r133])^ Precise analysis of the functions of each transcription factor is required to compensate their functions with chemical compounds.

3.3. Partial reprogramming with specific culture conditions.
------------------------------------------------------------

Some studies have utilized gene transduction combinations and external signals from culture media. In particular, initializing factors of iPSCs have frequently been used in combination with external signals. A wide variety of cells, *e.g.*, β cells,^[@r134])^ blood progenitor cells,^[@r135])^ cardiomyocytes,^[@r136])^ neural stem cells,^[@r137],[@r138])^ vascular endothelial cells,^[@r139])^ neural crest cells,^[@r140])^ hepatocytes,^[@r140])^ oligodendrocyte progenitor cells,^[@r141])^ and keratinocytes,^[@r142])^ were previously generated and transplanted into model animals. Although these protocols are time- and cost-effective compared with iPSC-employing methods, the risk of tumorigenesis caused by cell initialization remains to be elucidated.

3.4. MicroRNAs (miRNAs).
------------------------

miRNAs regulate the expression of specific mRNAs post-transcriptionally. Therefore, miRNAs can be used for direct reprogramming instead of or in combination with gene transduction. In a previous study, somatic cells were converted into several types of neuronal cells^[@r143]--[@r146])^ and cardiomyocytes.^[@r147]--[@r149])^ miRNA induction avoids the problem of transgene genome integration because the miRNA genes can be induced into cells as RNA. However, most of the reported studies employed gene transduction simultaneously for conversion. Complete miRNA-based reprogramming methods are expected to be developed in future.

3.5. Physical stimulations.
---------------------------

Several physical stimulations have been used as additional stimulations for direct reprogramming. Hypoxia conditions have been frequently employed in stem cell biology and control stem cell functions through the HIF signaling pathway.^[@r150])^ In a study involving direct reprogramming, these conditions were also used to accelerate conversion.^[@r151],[@r152])^ On the other hand, micro- or nano-imprinted patterns, *e.g.*, microgrooves, of cultured cell substrates are known as enhancers of reprogramming in biomaterials science. Biochemical and molecular biology studies are required to understand the effect of imprinted patterns for reprogramming.^[@r153]--[@r156])^ Of note, the electrical stimulation-induced direct reprogramming of fibroblasts into chondrocytes without any soluble factors or transgenes was reported recently.^[@r157])^ Elucidating the molecular mechanism of the reprogramming phenomenon may aid in the development of direct reprogramming technology.

3.6. Other methods.
-------------------

Several other innovative approaches have been applied in direct reprogramming studies, such as a CRISPR/Cas9-based method. A modified Cas9 protein, which has a domain for transcriptional activation and guides RNAs for the endogenous transcription factor genes, is introduced into source cells to activate endogenous transcription factors.^[@r71],[@r158])^ The genome integration-free protocols of the CRISPR/Cas9 system have already been established, thus, this method is also an integration-free method. Studies utilizing CRISPR-based direct reprogramming will increase because this method is straightforward and suitable for screening reprogramming factors.

Rational protein engineering of transcription factors is a unique approach translated from another field, *i.e.*, biomolecular engineering. Functional protein domains, such as VP16 or M3 of Myod, are attached to transcription factors to improve their transcriptional activities. Neuronal cells and cardiomyocytes have been induced successfully by using artificial transcription factors.^[@r159],[@r160])^

Additionally, the number of hybrid methods using the techniques above are increasing.^[@r161]--[@r166])^ In future, engineering-based approaches optimizing the reprogramming process will be considerably more important compared with previous stages.

4. Mechanism analyses and future applications of direct reprogramming
=====================================================================

To make direct reprogramming technology more efficient and safer for medical and industrial applications, analyses of the molecular and cellular mechanisms of cell fate conversion, *i.e.*, the transition of the transcriptome, the behavior of transcription factors, epigenetic remodeling, and the heterogeneity of cell populations, are essential (Fig. [2](#fig02){ref-type="fig"}). In addition, applied research on direct reprogramming technology in medicine and industry has increased in recent years toward practical use (Table [3](#tbl03){ref-type="table"}). Therefore, representatives of molecular and cellular mechanism analyses are introduced in this section. In addition, novel applications of direct reprogramming, including non-medical uses, are described.

4.1. Analyses of the molecular and cellular mechanisms of direct reprogramming.
-------------------------------------------------------------------------------

Regarding the mechanisms of direct cell fate conversion, the reprogramming processes of cardiomyocytes,^[@r148],[@r149],[@r165],[@r167]--[@r179])^ neuronal cells,^[@r39],[@r45],[@r48],[@r143],[@r145],[@r160],[@r180]--[@r188])^ and hepatocytes^[@r189]--[@r192])^ have been well-studied among the various direct reprogramming methods. Additionally, several studies regarding the direct reprogramming of other cell types, *e.g.*, neural stem/progenitor cells,^[@r193],[@r194])^ glial cells,^[@r195])^ photoreceptor cells,^[@r196])^ β cells,^[@r197])^ renal tubular epithelial cells,^[@r198])^ trophoblast stem cells,^[@r102])^ and mesodermal cells,^[@r199],[@r200])^ have been reported.

Several methodologies have been employed for the molecular biological analysis of direct reprogramming. Comprehensive transcriptome analyses using RNA-seq have been performed frequently, and differential expression gene analysis between source and target cells has provided a considerable amount of information regarding essential regulator genes and signaling pathways during conversion.^[@r143],[@r148],[@r176],[@r179],[@r180],[@r200])^ Epigenetic remodeling studies during cell-fate conversions have also been performed in various reprogrammed cells.^[@r44],[@r48],[@r171],[@r175],[@r177],[@r182],[@r188],[@r191],[@r194],[@r195])^ Histone modification and DNA methylation data clarified the drastic and rapid change in chromatin states in reprogrammed cells. In addition, detailed analysis of transduced and endogenously upregulated transcription factors was a critical task for understanding direct reprogramming. Several methods, such as loss-of-function, ChIP-seq, and mass spectrometry, have been used to analyze the function and behavior of transcription factors.^[@r102],[@r145],[@r160],[@r167],[@r169],[@r172],[@r173],[@r179],[@r184]--[@r186],[@r190],[@r195],[@r199])^ Transcription factor studies indicated that almost all of the reprogramming-related transcription factors played vital roles during the reprogramming process, *e.g.*, by remodeling histone and DNA modifications, initiating the target transcription network, and erasing the transcriptional signature of the source cells. Recently, the activities of specific transcription factors, termed pioneer factors, seem pivotal for remodeling the chromatin states of cell conversion.^[@r201])^ For example, Ascl1 was identified as a pioneer factor for the induction of iN cells, which can preferentially bind to chromatin and allowed the binding of other reprogramming factors used for iN cell induction.^[@r202])^ Additionally, in the case of iHep cell induction, well-known pioneer factors from the Foxa protein family are indispensable.^[@r55],[@r56],[@r58]--[@r64],[@r114],[@r115],[@r127],[@r189])^ Therefore, understanding the roles of pioneer factors will improve direct reprogramming technology. Additionally, the function of miRNA in iCMs has been thoroughly analyzed, and, therefore, miRNA-based reprogramming technologies of iCMs have been developed.^[@r148],[@r165],[@r177])^ The analysis of miRNAs in other direct reprogramming methods may result in their improvement. Other molecular and cellular analyses, such as signal transduction,^[@r174],[@r183],[@r197])^ metabolic remodeling,^[@r198])^ time-lapse imaging,^[@r170])^ and cell morphological studies,^[@r168])^ have been performed. Recently, single-cell analyses, such as single-cell RNA sequencing (scRNA-seq), have been performed in many direct reprogramming studies.^[@r149],[@r181],[@r187],[@r192],[@r199])^ These studies have clarified many features of direct reprogramming processes. For example, a limiting step and an obstruction factor,^[@r187])^ a stem cell-like transition state,^[@r181])^ and multiple trajectories^[@r192])^ of the direct cell fate conversions were discovered using scRNA-seq data. In the near future, other single-cell analysis techniques, such as ATAC-seq,^[@r203])^ ChIL-seq,^[@r204])^ CUT&RUN,^[@r205])^ and Hi-C,^[@r206])^ will reveal the chromatin dynamics and epigenetic remodeling processes in single converting cells during direct reprogramming processes.

4.2. Medical and industrial applications of direct reprogramming.
-----------------------------------------------------------------

As described above, most applied research for direct reprogramming has focused on clinical medicine, *i.e.*, cell transplantation and *in vivo* direct reprogramming therapies. Meanwhile, some non-medical applications have been reported in recent years (Table [3](#tbl03){ref-type="table"}). Direct reprogramming studies of disease model cells, which are induced from patient-derived cells, are necessary for basic studies of different disorders, and these cells can be employed for *in vitro* experiments for drug discovery. Indeed, a human iN cell type, instead of primary neuronal cells, was previously applied to *in vitro* drug treatment experiments.^[@r48])^ Additionally, several directly induced neuronal and skeletal muscle cell types from patients with various diseases have been reported.^[@r45]--[@r47],[@r104],[@r105],[@r207])^ Direct reprogramming technology has the potential to change the pharmaceutical industry. In direct reprogramming studies, cells from different species, *e.g.*, rat,^[@r208])^ pigs,^[@r208])^ dogs,^[@r209])^ goats,^[@r210])^ and marmosets,^[@r211])^ have been generated. Some of the animals studied were industrial animals, such as livestock or pets, since direct reprogramming technology might contribute to animal industries, such as veterinary medicine.

5. Summary
==========

Direct reprogramming is a promising technology that can convert somatic cells into various terminally differentiated or somatic stem/progenitor cell types for medical and industrial applications. Therefore, the number of studies utilizing this technology has increased rapidly in the last decade. Artificial cell fate conversions can be achieved with the forced expression of defined sets of transcription factors, treatment with chemical compounds as agonists or antagonists for various bioreactions, culturing with soluble factors or specific culture conditions, the induction of miRNA sets, appropriate physical stimulations, among other methods. Various cell types have been induced from somatic cells through direct reprogramming. Among them, neuronal cells, cardiomyocytes, and hepatocytes have been well-studied and their reprogramming mechanisms have been thoroughly analyzed. These technologies are expected to be applied in a variety of industries such as agriculture, biomaterial, healthcare, and medical industries.
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Examples of the direct reprogramming with defined transcription factors

  **Source cells**                                                                                                         **Target cells**                     **Transgenes and/or Treatment**                                    **Species**     **Cell** **transplantation**   **Published** **year**   **PMID**
  ------------------------------------------------------------------------------------------------------------------------ ------------------------------------ ------------------------------------------------------------------ --------------- ------------------------------ ------------------------ ---------------------------------------
  **Neuronal (stem) cells**                                                                                                                                                                                                                                                                                
  Astrocytes                                                                                                               Glutamatergic neurons                Pax6, Mash1, or Ngn2                                               Mouse                                          2007                     17687043^[@r25])^
  Embryonic fibroblasts and Hepatocytes                                                                                    Neuronal cells                       Brn2, Ascl1, and Myt1l                                             Mouse                                          2010, 2011               20107439^[@r26])^; 21962918^[@r212])^
  Astrocytes                                                                                                               GABAergic neurons                    Dlx2; Dlx2 and Ascl1                                               Mouse                                          2010                     20502524^[@r213])^
  Embryonic fibroblasts and Adult skin fibroblasts                                                                         Dopaminergic neurons                 Ascl1, Lmx1a, and Nurr1                                            Mouse & Human   YES                            2011                     21725324^[@r27])^
  Fetal fibroblasts and Postnatal foreskin fibroblasts                                                                     Neuronal cells                       BRN2, ASCL1, MYT1L, and NEUROD1                                    Human                                          2011                     21617644^[@r28])^
  Embryonic fibroblasts and Postnatal fibroblasts                                                                          Neuronal cells                       ASCL1, BRN2, MYT1L, LMX1A, and FOXA2                               Human                                          2011                     21646515^[@r29])^
  Embryonic fibroblasts                                                                                                    Neural stem cells                    Brn4/Pou3f4, Sox2, Klf4, c-Myc, and E47/Tcf3                       Mouse           YES                            2012                     22445517^[@r30])^
  Embryonic fibroblasts and Fetal foreskin fibroblasts                                                                     Neural stem cells                    Sox2                                                               Mouse & Human   YES                            2012                     22683203^[@r31])^
  Sertoli cells                                                                                                            Neural stem cells                    Pax6, Ngn2, Hes1, Id1, Ascl1, Brn2, c-Myc, and Klf4                Mouse           YES                            2012                     22064700^[@r32])^
  Fibroblasts (IMR90 cells)                                                                                                Dopaminergic neurons                 MASH1, NGN2, SOX2, NURR1, and PITX3 + A dominant-negative P53      Human           YES                            2014                     25129808^[@r216])^
  Non-sensory cochlear epithelial cells                                                                                    Neuronal cells                       Ascl1; Ascl1 and Neurod                                            Mouse                                          2014                     24928351^[@r39])^
  Astrocytes                                                                                                               Neuronal cells                       Brn4                                                               Mouse                                          2014                     24887289^[@r185])^
  Skin fibroblasts                                                                                                         Dopaminergic precursors              Brn2, Sox2, and Foxa2                                              Mouse           YES                            2015                     26224135^[@r217])^
  Adult skin fibroblasts                                                                                                   Motor neurons                        NEUROG2, SOX11, ISL1, and LHX3                                     Human                                          2016                     26725112^[@r46])^
  Fibroblasts (3T6 cells)                                                                                                  Neuronal cells                       Ascl1, Brn4, and Tcf3                                              Mouse                                          2017                     29137640^[@r219])^
  Umbilical cord blood cells                                                                                               Neural stem cells                    SOX2 and HMGA2                                                     Human                                          2017                     28844127^[@r33])^
  Fibroblasts (3T6 cells)                                                                                                  Neuronal cells                       Ascl1, Brn2, and Foxa1                                             Mouse                                          2017                     28855426^[@r119])^
  Resident glial cells                                                                                                     Neuronal cells                       Ascl1, Lmx1a, and Nurr1                                            Mouse                                          2017                     28844658^[@r41])^
  Fibroblast-like cells from retinal tissues                                                                               Neuronal cells                       ASCL1 and PAX6                                                     Human                                          2017                     28697461^[@r220])^
  Pluripotent stem cell- derived cardiomyocytes                                                                            Neuronal cells                       Brn2, Ascl1, Myt1l and Neurod                                      Mouse & Human                                  2017                     28327614^[@r221])^
  Fibroblasts                                                                                                              Motor neurons                        ASCL1, ISL1, NEUROD1, BRN2, HB9, LHX3, MYT1L, and NGN2             Human                                          2017                     28099929^[@r222])^
  Fibroblasts                                                                                                              Neurocytes                           SOX2, GATA3, and NEUROD1                                           Human                                          2017                     28587331^[@r62])^
  Dermal fibroblasts                                                                                                       Neural precursor cells               SOX2 and PAX6                                                      Human                                          2018                     30450440^[@r34])^
  Embryonic fibroblasts and Newborn foreskin fibroblasts                                                                   Neural stem cells                    Ptf1a                                                              Mouse & Human   YES                            2018                     30030434^[@r35])^
  Adult fibroblasts                                                                                                        Neural precursor cells               SOX2; SOX2 and PAX6; SOX2 and LMX1A; SOX2, LMX1A, and FOXA2        Human                                          2018                     30018471^[@r36])^
  Spiral ganglion non- neuronal cells                                                                                      Neuronal cells                       Ascl1 and Neurod                                                   Mouse                                          2018                     29492404^[@r223])^
  Umbilical cord mesenchymal stem cells                                                                                    Neuronal cells                       SOX2, ASCL1, and NEUROG2                                           Human                                          2018                     29937717^[@r224])^
  Pericytes                                                                                                                Neuronal cells                       ASCL1 and SOX2                                                     Human                                          2018                     29915193^[@r181])^
  Cord blood CD133(+) cells                                                                                                Neuronal cells                       FOXM1, SOX2, MYC, SALL4, and STAT6                                 Human                                          2018                     29653196^[@r38])^
  Hepatocytes                                                                                                              Neuronal cells                       Suz12, Ezh2, Meis1, Sry, Smarca4, Esr1, Pparg, and Stat3           Mouse                                          2018                     29653196^[@r38])^
  Peripheral CD34(+) cells                                                                                                 Neural stem cells                    AR, SOX2, SMAD3, MYC, JUN, WT1, TAL1, SPI1, and RUNX1              Human                                          2018                     29653196^[@r38])^
  Urine epithelial-like cells                                                                                              Neural stem cells                    POU3F2, SOX2, BACH1, AR, PBX1, and NANOG                           Human                                          2018                     29653196^[@r38])^
  Muller glia cells                                                                                                        Neural stem cells                    Bmi1, Spi1, Lmo2, and Cebpd                                        Mouse                                          2018                     29653196^[@r38])^
  Astrocytes and Foreskin fibroblasts                                                                                      Noradrenergic neurons                Ascl1, Phox2b, Ap-2a, Gata3, Hand2, Nurr1, and Phox2a              Mouse & Human   YES                            2019                     31315047^[@r225])^
  Bone marrow-derived cells, Fibroblasts, and Keratinocytes                                                                Neural precursor cells               MSI1, NGN2, and MBD2                                               Human           YES                            2019                     31196173^[@r37])^
  Microglial cells                                                                                                         Neuronal cells                       Neurod1                                                            Mouse                                          2019                     30638745^[@r44])^
  **Cardiomyocytes**                                                                                                                                                                                                                                                                                       
  Cardiac fibroblasts                                                                                                      Cardiomyocytes                       Gata4, Mef2c, and Tbx5                                             Mouse           YES                            2010                     20691899^[@r49])^
  Cardiac fibroblasts                                                                                                      Cardiomyocytes                       Gata4, Mef2c, Tbx5, and Hand2                                      Mouse                                          2012                     22660318^[@r50])^
  Cardiac fibroblasts and Embryonic fibroblasts                                                                            Cardiomyocytes                       Mef2c and Tbx5 + Myocd or Gata4                                    Mouse                                          2012                     22575762^[@r51])^
  Cardiac fibroblasts                                                                                                      Cardiomyocytes                       GATA4, MEF2C, TBX5, MESP1, and MYOCD                               Human                                          2013                     23861494^[@r52])^
  Embryonic stem cells- derived fibroblasts                                                                                Cardiomyocytes                       GATA4, MEF2C, TBX5, ESRRG, MESP1, ZFPM2, and MYOCD                 Human           YES                            2013                     24319660^[@r53])^
  Adult tail-tip fibroblasts and Cardiac fibroblasts                                                                       Cardiomyocytes                       Mef2c and Tbx5 + Bmi1 knockdown                                    Mouse                                          2016                     26942853^[@r175])^
  Adult fibroblasts                                                                                                        Cardiomyocytes                       Gata4, Hand2, Mef2c, Tbx5, and Znf281                              Mouse                                          2017                     28982760^[@r167])^
  **Hepatocytes**                                                                                                                                                                                                                                                                                          
  Embryonic fibroblasts and Adult dermal fibroblasts                                                                       Hepatocytes                          Hnf4a and Foxa1, Foxa2, or Foxa3                                   Mouse           YES                            2011                     21716291^[@r55])^
  Caudal fibroblasts                                                                                                       Hepatocytes                          Gata4, Hnf1a, and Foxa3 + p19^Arf^ knockdown                       Mouse           YES                            2011                     21562492^[@r56])^
  Embryonic fibroblasts                                                                                                    Hepatocytes                          HNF1A, HNF4A, HNF6, ATF5, PROX1, CEBPA, and MYC + TP53 knockdown   Human           YES                            2014                     24582926^[@r57])^
  Fetal and adult fibroblasts and Adipose tissue-derived mesenchymal stem cells                                            Hepatocytes                          FOXA3, HNF1A, and HNF4A + SV40 large T antigen                     Human           YES                            2014                     24582927^[@r58])^
  Fibroblasts (BJ and MRC-5 cells)                                                                                         Hepatocytes                          HNF1A and Any two of the three factors: FOXA1, FOXA3, and HNF4A    Human                                          2014                     24963715^[@r59])^
  Liver cells in mouse models of chronic liver disease                                                                     Hepatocytes                          Foxa3, Gata4, Hnf1a, and Hnf4a                                     Mouse                                          2016                     26923201^[@r60])^
  Fetal lung fibroblasts                                                                                                   Hepatocytes                          ATF5, PROX1, FOXA2, FOXA3, and HNF4A                               Human                                          2017                     29192290^[@r61])^
  Fibroblasts                                                                                                              Hepatocytes                          OCT4, FOXA2, HNF1A, and GATA3                                      Human                                          2017                     28587331^[@r62])^
  Embryonic fibroblasts                                                                                                    Hepatocytes                          Foxa3, Hnf1a, and Gata4                                            Mouse           YES                            2018                     29959867^[@r63])^
  Embryonic fibroblasts                                                                                                    Hepatocytes                          Hnf4a, Foxa3, Klf4, and c-Myc                                      Mouse           YES                            2019                     30635054^[@r64])^
  **Islet-related cells**                                                                                                                                                                                                                                                                                  
  Liver cells *in vivo*                                                                                                    β cells                              Pdx1                                                               Mouse                                          2000, 2003               10802714^[@r20])^; 12775714^[@r21])^
  Pancreatic exocrine cells *in vivo*                                                                                      β cells                              Ngn3, Pdx1, and Mafa                                               Mouse                                          2008                     18754011^[@r65])^
  Hepatocytes                                                                                                              Islet cells                          Ngn3                                                               Mouse                                          2009                     19793886^[@r24])^
  Liver cells                                                                                                              β cells                              PDX1, PAX4, and MAFA                                               Human                                          2014                     24504462^[@r66])^
  Cultured adult pancreatic duct cells                                                                                     β cells                              Pdx1, Ngn3, and Mafa                                               Mouse                                          2015                     25836667^[@r67])^
  Gallbladder cells                                                                                                        β cells                              Pdx1, Ngn, Mafa, and Pax6                                          Mouse           YES                            2016                     27833043^[@r68])^
  **Hematopoietic system-related cells**                                                                                                                                                                                                                                                                   
  T precursor cells                                                                                                        Macrophages                          Cebpa or Cebpb                                                     Mouse                                          2006                     17088084^[@r22])^
  T precursor cells                                                                                                        Dendritic cells                      Pu.1                                                               Mouse                                          2006                     17088084^[@r22])^
  B cells                                                                                                                  T cells                              Pax5 knockout                                                      Mouse           YES                            2007                     17851532^[@r73])^
  Fibroblasts (3T3 cells), Embryonic fibroblasts, and Adult skin fibroblasts                                               Macrophage-like cells                Pu.1 and Cebpa or Cebpb                                            Mouse                                          2008                     18424555^[@r74])^
  B cells                                                                                                                  Erythroid cells                      Gata1, Scl, and Cebpa                                              Mouse                                          2012                     22968040^[@r214])^
  Fibroblasts (3T3 cells) and Adult dermal fibroblasts                                                                     Megakaryocyte                        Nfe2, Mafg, and Mafk                                               Mouse & Human   YES                            2012                     22855609^[@r75])^
  Skin fibroblasts                                                                                                         Monocytes                            Spl1, Cebpa, Mnda, and Irf8                                        Mouse                                          2012                     22428058^[@r76])^
  Embryonic fibroblasts and Adult ear skin fibroblasts                                                                     Hematopoietic progenitor cells       Erg, Gata2, Lmo2, Runx1c, and Scl                                  Mouse           YES                            2014                     25466247^[@r77])^
  Fibroblasts                                                                                                              Antigen-presenting dendritic cells   Pu.1, Irf8, and Batf3                                              Mouse & Human                                  2018                     30530727^[@r78])^
  **Bone-related cells**                                                                                                                                                                                                                                                                                   
  Neonatal foreskin fibroblasts                                                                                            Chondrogenic cells                   c-MYC, KLF4, and SOX9                                              Human           YES                            2013                     24146984^[@r215])^
  Dermal fibroblasts                                                                                                       Osteoblasts                          OCT3/4 and OCT6 or OCT9 + L-MYC, c-MYC, or N-MYC                   Human                                          2015                     26499074^[@r79])^
  Fibroblasts                                                                                                              Osteoblasts                          RUNX2, OCT4, OSTERIX, and L-MYC                                    Human           YES                            2015                     25918395^[@r80])^
  Gingival fibroblasts and Adult dermal fibroblasts                                                                        Osteoblasts                          OCT4, OSTERIX, and L-MYC                                           Human           YES                            2016                     26990860^[@r81])^
  Embryonic fibroblasts                                                                                                    Osteoblasts                          c-Myc, Oct4, and hLMP3                                             Mouse           YES                            2019                     30453092^[@r82])^
  **Skeletal muscle-related cells**                                                                                                                                                                                                                                                                        
  Fibroblasts (C3H10T1/2 cells)                                                                                            Myoblasts                            Myod                                                               Mouse                                          1987                     3690668^[@r19])^
  Dermal fibroblasts                                                                                                       Myoblasts                            MYOD1 and MYCL                                                     Human           YES                            2017                     28501623^[@r83])^
  Embryonic fibroblasts                                                                                                    Skeletal muscle progenitor cells     Mef2b and Pitx1 + Pax3 or Pax7                                     Mouse           YES                            2018                     28808339^[@r84])^
  Adult fibroblasts                                                                                                        Skeletal muscle progenitor cells     Pax7, Mef2b, and Myod                                              Mouse           YES                            2018                     28808339^[@r84])^
  **Other cells**                                                                                                                                                                                                                                                                                          
  Embryonic fibroblasts and Newborn foreskin fibroblasts                                                                   Brown fat cells                      Prdm16 and Cebpb                                                   Mouse & Human   YES                            2009                     19641492^[@r95])^
  Embryonic fibroblasts                                                                                                    Sertoli cells                        Nr5a1, Wt1, Dmrt1, Gata4, and Sox9                                 Mouse           YES                            2012                     22958931^[@r96])^
  Iris-derived cells                                                                                                       Photoreceptor cells                  CRX, RAX, and NEUROD                                               Human                                          2012                     22558175^[@r85])^
  Embryonic fibroblasts and Adult tail-tip dermal fibroblasts                                                              Melanocytes                          Mitf, Sox10, and Pax3                                              Mouse & Human   YES                            2014                     25510211^[@r97])^
  Adipose tissue-derived stromal cells                                                                                     Endothelial cells                    SOX18                                                              Human                                          2014                     25290189^[@r93])^
  Dermal fibroblasts                                                                                                       Photoreceptor cells                  CRX, RAX, OTX2, and NEUROD                                         Human                                          2014                     24456169^[@r86])^
  Embryonic fibroblasts                                                                                                    Thymic epithelial cells              Foxn1                                                              Mouse           YES                            2014                     25150981^[@r98])^
  Fibroblasts                                                                                                              Sweat gland cells                    NF-κB and LEF-1                                                    Human           YES                            2015                     26566868^[@r91])^
  Amniotic fluid stem cells                                                                                                Pluripotent stem cells               OCT4                                                               Human                                          2016                     27019637^[@r218])^
  Cardiac mesenchymal progenitors                                                                                          Adipocytes                           Klf4 and c-Myc                                                     Mouse                                          2016                     27077806^[@r87])^
  Embryonic fibroblasts, Adult tail-tip dermal fibroblasts, Postnatal foreskin fibroblasts, and Fetal dermal fibroblasts   Renal tubular epithelial cells       Emx2, Hnf1b, Hnf4a, and Pax8                                       Mouse & Human   YES                            2016                     27820600^[@r99])^
  Endothelial progenitor cells                                                                                             Smooth muscle cells                  MYOCD                                                              Human                                          2016                     26874281^[@r89])^
  Embryonic stem cells                                                                                                     Trophoblast stem cells               Cdx2, Arid3a, and Gata3                                            Mouse                                          2017                     28973471^[@r102])^
  Embryonic fibroblasts and Adult tail-tip dermal fibroblasts                                                              Leydig cells                         Dmrt1, Gata4, and Nr5a1                                            Mouse           YES                            2017                     28017657^[@r101])^
  Postnatal dermal fibroblasts                                                                                             Endothelial cells                    ER71/ETV2 (ETS variant 2)                                          Human           YES                            2017                     28003219^[@r94])^
  Dermal fibroblasts                                                                                                       Adipocytes                           PPARG2                                                             Human                                          2017                     28982679^[@r88])^
  Embryonic fibroblasts and Umbilical vein endothelial cells                                                               Intestine progenitor cells           Hnf4a, Foxa3, Gata6, and Cdx2                                      Mouse & Human   YES                            2017                     28943029^[@r100])^
  Embryonic fibroblasts and Adult dermal fibroblasts                                                                       Smooth muscle cells                  Myocd, Gata6, and Mef2c                                            Mouse & Human                                  2018                     30026272^[@r90])^
  Epidermal cells                                                                                                          Sweat gland cells                    Foxc1                                                              Mouse           YES                            2019                     30894517^[@r92])^
  Renal proximal tubular epithelial (HK2) cells                                                                            Nephron progenitor cells             SNAI2, EYA1, and SIX1                                              Human                                          2019                     30827514^[@r103])^

###### 

Examples of the direct reprogramming with various methods

  **Source cells**                                                                               **Target cells**                          **Transgenes and/or Treatment**                                                                    **Species**     **Cell** **transplantation**   **Published** **year**   **PMID**
  ---------------------------------------------------------------------------------------------- ----------------------------------------- -------------------------------------------------------------------------------------------------- --------------- ------------------------------ ------------------------ --------------------
  **Integration-free transduction**                                                                                                                                                                                                                                                                                   
  Fibroblasts (BJ and MRC-5 cells)                                                               Hepatocytes                               HNF1A and Any two of the three factors: FOXA1, FOXA3, and HNF4A (mRNA transfection)                Human                                          2014                     24963715^[@r59])^
  Non-sensory cochlear epithelial cells                                                          Neuronal cells                            Ascl1; Ascl1 and Neurod (plasmid electroporation)                                                  Mouse                                          2014                     24928351^[@r39])^
  Cardiac fibroblasts                                                                            Cardiomyocytes                            Gata4, Mef2c, and Tbx5 (peptide-enhanced mRNA transfection)                                        Mouse                                          2015                     25834424^[@r116])^
  Astrocytes                                                                                     Neural stem cells                         Sox2 (Leu3p-αIPM system)                                                                           Mouse                                          2016                     27148066^[@r121])^
  Fetal and embryonic fibroblasts and Brain cells *in vivo*                                      Neuronal cells                            Ascl1, Brn2, and Myt1l (mRNA transfection with a GO-PEI-based reagent *in vitro* and *in vivo*)    Mouse & Human                                  2016                     28145631^[@r40])^
  Peripheral blood mononuclear cells                                                             Photoreceptor cells                       CRX, RAX1, and NEUROD1 (SeV infection)                                                             Human                                          2016                     27170256^[@r112])^
  Gingival fibroblasts and Adult dermal fibroblasts                                              Osteoblasts                               OCT4, OSTERIX, and L-MYC (plasmid transfection)                                                    Human           YES                            2016                     26990860^[@r81])^
  Fibroblasts                                                                                    Hepatocytes                               OCT4, FOXA2, HNF1A, and GATA3 (protein transduction with HVJ-E)                                    Human                                          2017                     28587331^[@r62])^
  Fibroblasts                                                                                    Neurocytes                                SOX2, GATA3, and NEUROD1 (protein transduction with HVJ-E)                                         Human                                          2017                     28587331^[@r62])^
  Fibroblasts (3T6 cells)                                                                        Neuronal cells                            Ascl1, Brn2, and Foxa1 (plasmid transfection with a polysaccharide-based reagent)                  Mouse                                          2017                     28855426^[@r119])^
  Mesenchymal stem cells                                                                         Hepatocytes                               Hnf4a and Foxa3 (PiggyBac transposon)                                                              Mouse                                          2017                     28295042^[@r114])^
  Dermal fibroblasts                                                                             Endothelial progenitor cells              ETV2 (mRNA transfection)                                                                           Human           YES                            2017                     27778229^[@r117])^
  Fibroblasts (3T6 cells)                                                                        Neuronal cells                            Ascl1, Brn4, and Tcf3 (plasmid transfection with a polysaccharide-based reagent)                   Mouse                                          2017                     29137640^[@r120])^
  Mesenchymal stem cells and Dermal fibroblasts                                                  Neural stem cells                         SOX2 (mRNA transfection)                                                                           Human                                          2018                     29909688^[@r118])^
  Adult fibroblasts                                                                              Neural precursor cells                    SOX2; SOX2 and PAX6; SOX2 and LMX1A; SOX2, LMX1A, and FOXA2 (plasmid transfection)                 Human                                          2018                     30018471^[@r36])^
  Dermal fibroblasts                                                                             Neural precursor cells                    SOX2 and PAX6 (chemically modified mRNA or plasmid transfection)                                   Human                                          2018                     30450440^[@r34])^
  Embryonic fibroblasts                                                                          Hepatocytes                               Hnf4a and Foxa3 (modified mRNA transfection)                                                       Mouse           YES                            2018                     30327781^[@r115])^
  Foreskin fibroblasts                                                                           Neuronal cells                            ASCL1 + miR-124 + P53 knockdown (episomal plasmid transfection)                                    Human                                          2019                     30539819^[@r122])^
  Bone marrow-derived cells, Fibroblasts, and Keratinocytes                                      Neural precursor cells                    MSI1, NGN2, and MBD2 (plasmid transfection)                                                        Human           YES                            2019                     31196173^[@r37])^
  Renal proximal tubular epithelial (HK2) cells                                                  Nephron progenitor cells                  SNAI2, EYA1, and SIX1 (PiggyBac transposon)                                                        Human                                          2019                     30827514^[@r103])^
  **Chemical compounds (with or without transcription factors)**                                                                                                                                                                                                                                                      
  Fibroblasts (IMR90 or MRC5 cells)                                                              Cholinergic neurons                       NGN2 + Forskolin and dorsomorphin treatment                                                        Human                                          2013                     23873306^[@r130])^
  Embryonic fibroblasts and Neonatal tail-tip fibroblasts                                        Cardiomyocytes                            CHIR99021, RepSox, Forskolin, Valproic acid, Parnate, and TTNPB treatment                          Mouse                                          2015                     26292833^[@r123])^
  Embryonic fibroblasts and Adult tail-tip fibroblasts                                           Neural stem cells                         Valproic acid, Bix01294, RG108, PD0325901, CHIR99021, Vitamin C, and A83-01 treatment              Mouse           YES                            2015                     26788068^[@r124])^
  Fibroblasts                                                                                    Neuronal cells                            Valproic acid, CHIR99021, RepSox, Forskolin, SP600125, GO6983, and Y-27632 treatment               Human                                          2015                     26253202^[@r125])^
  Fibroblasts                                                                                    Neuronal cells                            ISX9, SB431542, Forskolin, CHIR99021, and I-BET151 treatment                                       Mouse                                          2015                     26253201^[@r126])^
  Embryonic fibroblasts                                                                          Neural stem cells                         A83-01, Purmorphamine, Valproic acid, and Thiazovivin treatment                                    Mouse                                          2017                     27207831^[@r131])^
  Urine-derived cells                                                                            Hepatocytes                               FOXA3 and HNF1A or HNF4A + CHIR99021, RepSox, Valproic acid, Parnate, TTNPB, and Dznep treatment   Human                                          2018                     30315254^[@r127])^
  Embryonic and adult fibroblasts                                                                Skeletal muscle progenitor cells          Myod + CHIR99021, RepSox, and Forskolin treatment                                                  Mouse           YES                            2018                     29742392^[@r128])^
  Adult dermal fibroblasts, Fetal pancreas fibroblasts, and Peripheral blood mononuclear cells   Neural plate border stem cells            BRN2, KLF4, SOX2, and ZIC3 + CHIR99021, ALK5 inhibitor, Purmorphamine, Tranylcypromine treatment   Human           YES                            2018                     30581079^[@r132])^
  Striatal neurons                                                                               Dopaminergic neurons                      Sox2, Nurr1, Lmx1a, and Foxa2 + Valproic acid treatment (*in vivo* infection)                      Mouse                                          2018                     30318292^[@r42])^
  Glioblastoma cells (U87MG cells)                                                               Neuronal cells                            Forskolin, ISX9, CHIR99021, I-BET151, and DAPT treatment                                           Human                                          2018                     30091580^[@r129])^
  Dermal fibroblasts                                                                             Neuronal cells                            NGN2 and ASCL1 + Pyrintegrin, ZM336372, AZ960, and KC7F2 treatment                                 Human                                          2019                     31099332^[@r133])^
  **Culture condition and soluble factors (with transcription factors)**                                                                                                                                                                                                                                              
  Liver cells *in vivo*                                                                          β cells                                   PDX1 + EGF and nicotinamide treatment                                                              Human           YES                            2005                     15899968^[@r134])^
  Adult dermal fibroblasts and Neonatal foreskin fibroblasts                                     Multilineage blood progenitor cells       OCT4 + hematopoietic cytokines treatment                                                           Human           YES                            2010                     21057492^[@r135])^
  Embryonic fibroblasts                                                                          Cardiomyocytes                            OSKM + cytokines (including Bmp4) treatment                                                        Mouse                                          2011                     21278734^[@r136])^
  Adult skin fibroblasts                                                                         Neural stem cells                         OSKM + neurosphere culture                                                                         Mouse           YES                            2012                     22467474^[@r137])^
  Amniocytes                                                                                     Vascular endothelial cells                ETV2, FLI1, and ERG1 + TGFβ inhibitor treatment                                                    Human           YES                            2012                     23084400^[@r139])^
  Embryonic stem cells-derived fibroblasts                                                       Neural crest cells                        SOX10 + Environmental cues including WNT activation                                                Human           YES                            2014                     25158936^[@r140])^
  Newborn fibroblasts                                                                            Hepatocytes                               OSK + Soluble factors                                                                              Human           YES                            2014                     24572354^[@r226])^
  Dermal fibroblasts                                                                             Oligodendrocyte progenitor cells          Oct4 + OPC induction medium                                                                        Mouse           YES                            2015                     26497893^[@r141])^
  Embryonic fibroblasts                                                                          Keratinocytes                             OSK + Bmp4 and RA treatment                                                                        Mouse           YES                            2016                     27473056^[@r142])^
  Skin fibroblasts                                                                               Neural stem cells                         OCT3/4, SOX2, KLF4, L-MYC, and LIN28 + P53 knockdown + Neurotrophins treatment                     Human                                          2016                     27822179^[@r138])^
  **miRNAs (with or without transcription factors)**                                                                                                                                                                                                                                                                  
  Cardiac fibroblasts                                                                            Cardiomyocytes                            miR-1, miR-133, miR-208, and miR-499                                                               Mouse                                          2012                     22539765^[@r147])^
  Embryonic fibroblasts                                                                          Neuronal cells                            Ptb knockdown                                                                                      Mouse                                          2013                     23313552^[@r143])^
  Cardiac fibroblasts and Embryonic fibroblasts                                                  Cardiomyocytes                            Gata4, Mef2c, and Tbx5 + miR-133; Gata4, Mef2c, Tbx5, Mesp1, and Myocd + miR-133                   Mouse & Human                                  2014                     24920580^[@r148])^
  Adult dermal fibroblasts, Umbilical cord blood cells, and Senescent somatic cells              Neural stem cells                         SOX2 + HMGA2 expression or LET-7B inhibition                                                       Human           YES                            2015                     25600877^[@r144])^
  Fibroblasts                                                                                    Cardiomyocytes                            GATA4, MEF2C, TBX5, ESRRG, MESP1, MYOCARDIN, ZFPM2, and HAND2 + miR-1                              Human                                          2017                     28796841^[@r149])^
  Adult fibroblasts                                                                              Neuronal cells                            miR-9/9\* and miR-124                                                                              Human                                          2017                     28886366^[@r145])^
  Adult fibroblasts                                                                              Spinal cord motor neurons                 ISL1 and LHX3 + miR-9/9\* and miR-124                                                              Human                                          2017                     28886366^[@r145])^
  Brain vascular pericytes                                                                       Cholinergic neuronal cells                ASCL1, MYT1L, BRN2, and TLX3 + miR-124                                                             Human           YES                            2018                     29453933^[@r146])^
  **Physical stimulation (with or without transcription factors)**                                                                                                                                                                                                                                                    
  Embryonic fibroblasts                                                                          Neuronal cells                            Ascl1, Brn2, and Myt1l + Substrate topography                                                      Mouse                                          2014                     24709523^[@r153])^
  Fibroblasts                                                                                    Cardiomyocytes                            Myocardin, Tbx5, and Mef2c + Microgroove                                                           Mouse                                          2015                     26302234^[@r154])^
  Embryonic fibroblasts                                                                          Dopaminergic neurons                      Ascl1, Pitx3, Nurr1, and Lmx1a + Nanogroove                                                        Mouse                                          2015                     25662493^[@r155])^
  Dermal fibroblasts                                                                             Endothelial progenitor cells              ETV2 + Hypoxia                                                                                     Human                                          2016                     27488544^[@r151])^
  Neonatal tail-tip fibroblasts                                                                  Cardiomyocytes                            Gata4, Mef2c, and Tbx5 + Microgroove                                                               Mouse                                          2016                     27376554^[@r156])^
  Fibroblasts                                                                                    Cardiomyocytes                            Gata4, Mef2c, and Tbx5 + Hypoxia                                                                   Mouse                                          2016                     26757100^[@r152])^
  Dermal fibroblasts                                                                             Chondrocytes                              Electrical stimulation                                                                             Human                                          2019                     31005261^[@r157])^
  **CRISPR/Cas9-based methods**                                                                                                                                                                                                                                                                                       
  Embryonic fibroblasts                                                                          Neuronal cells                            CRISPR/Cas9-based transcriptional activators + gRNAs for Brn2, Ascl1, and Myt1l                    Mouse                                          2016                     27524438^[@r158])^
  Liver cells *in vivo*                                                                          β cells                                   CRISPR/Cas9-based transcriptional activators + gRNA for Pdx1 (*in vivo* infection)                 Mouse           YES                            2017                     29224783^[@r71])^
  **Protein engineering (with transcription factors)**                                                                                                                                                                                                                                                                
  Embryonic fibroblasts                                                                          Cardiomyocytes                            Gata4, Tbx5, and Hand2 + Mef2c fused with M3 domain of Myod                                        Mouse                                          2013                     23794713^[@r159])^
  Astrocytes                                                                                     Neuronal cells                            Ascl1, Creb-VP16, and Icer                                                                         Mouse                                          2017                     28321434^[@r160])^
  **Other methods**                                                                                                                                                                                                                                                                                                   
  Bone marrow stromal cells                                                                      Renal proximal tubular epithelial cells   HK2 cell-extracts treatment + streptolysin O                                                       Human           YES                            2015                     25754206^[@r161])^
  Embryonic fibroblasts                                                                          Cardiomyocytes                            Gata4, Hand2, Mef2c, and Tbx5 + miR-1 and miR-133 + TGFβ inhibitors or ROCK inhibitors             Mouse                                          2015                     26354680^[@r162])^
  Pancreatic exocrine cells                                                                      β cells                                   Pdx1, Ngn3, and Mafa (synthetic mRNA transfection) + 5-Aza treatment                               Mouse                                          2016                     27187823^[@r163])^
  Neonatal cardiac and tail-tip fibroblasts                                                      Cardiomyocytes                            miR-1, miR-133, miR-208, and miR-499 + three-dimensional culture                                   Mouse                                          2016                     27941896^[@r164])^
  Neonatal cardiac and tail-tip fibroblasts                                                      Cardiomyocytes                            miR-1, miR-133, miR-208, and miR-499 + Reprogramming medium                                        Mouse                                          2016                     26975336^[@r165])^
  Adipose-derived stem cells and Neonatal foreskin fibroblasts                                   Neural stem cells                         iPSC induction followed by TRA-1-60--/SSEA4--selection                                             Human           YES                            2016                     27569063^[@r166])^
  Fibroblasts                                                                                    Adipocytes                                OCT4 and C/EBPB (protein transduction with HVJ-E) + Adipogenic differentiation medium              Human                                          2017                     28587331^[@r62])^

###### 

Applications of the directly reprogrammed cells

  **Source cells**                                       **Target cells**                                                   **Transgenes and/or Treatment**                                                 **Species**             **Published year**   **PMID**
  ------------------------------------------------------ ------------------------------------------------------------------ ------------------------------------------------------------------------------- ----------------------- -------------------- --------------------------------------
  ***In vivo* reprogramming (regenerative medicine)**                                                                                                                                                                                                    
  Liver cells                                            β cells                                                            Pdx1 (an adenoviral vectors)                                                    Mouse                   2000, 2003           10802714^[@r20])^; 12775714^[@r21])^
  Pancreatic exocrine cells                              β cells                                                            Ngn3, Pdx1, and Mafa (an adenoviral vector)                                     Mouse                   2008                 18754011^[@r65])^
  Cardiac fibroblasts                                    Cardiomyocytes                                                     Gata4, Mef2c, Tbx5, and Hand2 (a retrovirus vector)                             Mouse                   2012                 22660318^[@r50])^
  Cardiac fibroblasts                                    Cardiomyocytes                                                     miR-1, miR-133, miR-208, and miR-499 (a lentiviral vector)                      Mouse                   2012                 22539765^[@r54])^
  Non-sensory cochlear epithelial cells                  Neuronal cells                                                     Ascl1; Ascl1 and Neurod (*in vivo* plasmid electroporation)                     Mouse                   2014                 24928351^[@r39])^
  Liver cells in mouse models of chronic liver disease   Hepatocytes                                                        Foxa3, Gata4, Hnf1a, and Hnf4a (an AAV vector)                                  Mouse                   2016                 26923201^[@r60])^
  Brain cells *in vivo*                                  Neuronal cells                                                     Ascl1, Brn2, and Myt1l (mRNA transfection with a GO-PEI-based reagent)          Mouse                   2016                 28145631^[@r40])^
  Bile duct cells                                        β cells                                                            Pdx1, Ngn3, and Mafa (an adenoviral vector)                                     Mouse                   2017                 28363269^[@r69])^
  Hepatocytes                                            β cells                                                            Pdx1, Ngn3, and Mafa (hydrodynamics tail vein injection)                        Mouse                   2017                 28100871^[@r70])^
  Resident glial cells                                   Neuronal cells                                                     Ascl1, Lmx1a, and Nurr1 (an AAV vector)                                         Mouse                   2017                 28844658^[@r41])^
  Liver cells *in vivo*                                  β cells                                                            CRISPR/Cas9-based transcriptional activators + gRNA for Pdx1 (an AAV vector)    Mouse                   2017                 29224783^[@r71])^
  Striatal neurons                                       Dopaminergic neurons                                               Sox2, Nurr1, Lmx1a, and Foxa2 (a lentiviral vector) + Valproic acid treatment   Mouse                   2018                 30318292^[@r42])^
  Resident glial cells                                   Interneurons                                                       Ascl1, Lmx1a, and Nurr1 (an AAV vector)                                         Mouse                   2019                 31259901^[@r43])^
  Microglial cells                                       Neuronal cells                                                     Neurod1 (a lentiviral vector)                                                   Mouse                   2019                 30638745^[@r44])^
  **Disease model**                                                                                                                                                                                                                                      
  Fibroblasts from Huntington\'s disease patients        Neuronal cells                                                     PTB1 knockdown                                                                  Human                   2014                 25275533^[@r45])^
  Urine-derived cells from muscle diseases patients      Skeletal muscle cells                                              MYOD                                                                            Human                   2016                 27651888^[@r104])^
  TSC2 gene-inactivated fibroblasts (CRISPR knockout)    Neuronal cells                                                     ASCL1, LMX1A, and NURR1                                                         Human                   2016                 27857203^[@r207])^
  Adult skin fibroblasts from ALS patients               Motor neurons                                                      NEUROG2, SOX11, ISL1, and LHX3                                                  Human                   2016                 26725112^[@r46])^
  Dermal fibroblasts from metabolic disease patients     Adipocytes                                                         PPARG2                                                                          Human                   2017                 28982679^[@r88])^
  Fibroblasts from BMD patients                          Skeletal muscle cells                                              MYOD                                                                            Human                   2018                 30171539^[@r105])^
  Fibroblasts from MERRF patients                        Neuronal cells                                                     ASCL1 and BRN2 + REST complex knockdown                                         Human                   2019                 30797798^[@r47])^
  **Other animals**                                                                                                                                                                                                                                      
  Embryonic fibroblasts                                  Neuronal cells                                                     ASCL1, BRN2, MYT1L, and NEUROD1                                                 Marmoset                2014                 24694048^[@r211])^
  Skin fibroblasts                                       Cardiomyocytes                                                     GATA4, HAND2, TBX5, and MEF2C                                                   Canine                  2015                 26681949^[@r209])^
  Cardiac fibroblasts                                    Cardiomyocytes                                                     Gata4, Mef2c, and Tbx5 + miR-590                                                Rat, Porcine, & Human   2016                 27930352^[@r208])^
  Fetal fibroblasts                                      Cardiomyocytes, Neurocytes, Oocytes, and Cumulus granulosa cells   OSKM + Lineage-specific medium                                                  Goat                    2017                 27629151^[@r210])^
  **Drug discovery**                                                                                                                                                                                                                                     
  Embryonic stem cells                                   Neuronal cells                                                     NGN2                                                                            Human                   2019                 31155484^[@r48])^

[^1]: (Edited by Shinya YAMANAKA, M.J.A.)
